{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-083248","form_type":"8-K","ticker":"QNRX","cik":"0001671502","company_name":"Quoin Pharmaceuticals, Ltd.","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.602244+00:00","generated_at":"2026-05-17T09:44:05.621371+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Quoin finalizes CFO exit: $433K lieu of notice, $108K bonus, extended options","bullets":["Separation agreement signed August 21; effective August 15, 2025.","Dunn receives $433,620 in bi-weekly installments in lieu of 12 months' notice.","Additional $108,405 bonus for FY2024 paid in lump sum after 12 months.","Vested stock options post-termination exercise period extended to 1 year 9 months from 90 days.","Agreement includes mutual release of claims; no admission of liability."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-083248","json":"https://secwatch.observer/filing/0001104659-25-083248.json","markdown":"https://secwatch.observer/filing/0001104659-25-083248.md","text":"https://secwatch.observer/filing/0001104659-25-083248.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925083248/0001104659-25-083248-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671502/000110465925083248/tm2524439d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:44:05.621371+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}